UPDATED Apr 09, 2024
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ARGX | €384.14 | -3.3% | 2.5% | €21.0b | €477.74 | PS18x | E56.3% | n/a | ||
SBFM | US$0.096 | 16.6% | -85.3% | US$9.6m | US$3.00 | PB0.4x | E134.4% | n/a | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
IOVA | US$13.22 | -4.0% | 140.4% | US$3.7b | US$26.00 | PS3105.5x | E61.7% | n/a | ||
RYTM | US$43.61 | 8.9% | 135.5% | US$2.5b | US$57.22 | PS34.3x | E61.1% | n/a | ||
CASI | US$3.13 | -10.8% | 11.8% | US$40.4m | US$12.00 | PS1.2x | E57.6% | n/a | ||
MESO | AU$5.85 | -11.2% | -16.9% | AU$1.0b | AU$7.07 | PS92.1x | E64.4% | n/a | ||
VCEL | US$50.34 | -1.8% | 63.8% | US$2.4b | US$53.07 | PS12.3x | E49.4% | n/a | ||
GNFT.F | €2.98 | 0% | n/a | €161.1m | €8.63 | PS4.2x | E54.7% | n/a | ||
ARGN.F | €383.74 | 0% | n/a | €21.0b | €477.24 | PS18x | E56.3% | n/a | ||
FRLN | US$6.48 | -0.2% | -21.7% | US$28.3m | US$8.25 | PS45.4x | E60.7% | n/a | ||
IMMP | AU$2.67 | 5.1% | 66.9% | AU$481.5m | AU$8.54 | PS122.5x | E60.3% | n/a | ||
SRRA | US$54.99 | 0.06% | 179.4% | US$1.3b | US$55.00 | PB5.1x | E69.5% | n/a | ||
CASB.F | HK$2.10 | 12.9% | -59.8% | HK$9.2b | HK$2.89 | PS12.2x | E124.2% | 0% | ||
PTGX | US$29.13 | 4.1% | 58.8% | US$1.6b | US$43.00 | PS28.3x | E50.0% | n/a | ||
LEGN | US$56.36 | -0.1% | 11.5% | US$10.0b | US$86.32 | PS36x | E61.9% | n/a | ||
ARCT | US$31.66 | -1.7% | 17.4% | US$832.5m | US$67.89 | PS5.1x | E60.7% | n/a | ||
BPMC | US$92.20 | 0.7% | 108.6% | US$5.6b | US$97.38 | PS22.6x | E66.2% | n/a | ||
YS | US$0.85 | 13.5% | -43.3% | US$165.7m | US$4.29 | PS2.1x | E56.6% | n/a | ||
GERN | US$3.43 | 10.6% | 70.6% | US$2.0b | US$5.08 | PS8522.5x | E62.1% | n/a | ||
ADMA | US$6.11 | -5.1% | 89.2% | US$1.4b | US$8.38 | PS5.4x | E32.5% | n/a | ||
ICPT | US$19.00 | 0.1% | 19.1% | US$794.7m | US$19.00 | PS2.5x | E42.4% | n/a | ||
DVAX | US$12.02 | -2.4% | 11.7% | US$1.6b | US$24.67 | PS6.8x | E41.6% | n/a | ||
PHAR | €10.00 | -7.1% | -16.1% | €663.7m | €20.29 | PS2.9x | E52.9% | n/a |